Residual TYK2 Signalling is Associated with Non-Response to Vedolizumab and Systemic TNF Inhibitors among Patients with Ulcerative Colitis: Post Hoc Analyses of Mucosal Transcriptome Data

M. Paraskevopoulou, J. Tang, B. Saha, A. Sugiura, V Arunachalam,S. Farahmand, R. Hou, J. Arevalo,C. Agboton, P. Panchal, N. Singh, I Petrakis, N. Desch,S. Schreiber

JOURNAL OF CROHNS & COLITIS（2025）

引用 0|浏览0